Your session is about to expire
← Back to Search
Clinical Decision Support Tool
Electronic Medical Record Support for Diabetes Management
N/A
Recruiting
Led By Ariana Pichardo-Lowden, MD
Research Sponsored by Milton S. Hershey Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Hospitalized adult (>18 years) patients at Penn State Health, Hershey Medical Center, St. Joseph's Hospital, Hampden Medical Center, and Holy Spirit Medical Center
Ambulatory adult (>18 years) patients at Penn State Health, Hershey Medical Center
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 24 months
Awards & highlights
Study Summary
This trial looks at whether using an electronic medical record clinical decision support tool can help manage dysglycemia in the hospital and improve outcomes.
Who is the study for?
This trial is for adults over 18 years old with conditions like prediabetes, diabetes, and varying blood sugar levels who are hospitalized or visiting outpatient clinics at specific Penn State Health centers. Children under 18 cannot participate.Check my eligibility
What is being tested?
The study is testing an electronic tool that helps doctors make decisions about diabetes care in hospitals. It looks at how the tool affects blood sugar control and its impact on clinical outcomes and costs.See study design
What are the potential side effects?
Since this trial involves a decision support tool rather than medication, traditional side effects are not applicable. However, there may be indirect effects on patient care based on the tool's recommendations.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am an adult patient hospitalized at a specified Penn State Health center.
Select...
I am over 18 and can walk on my own. I am a patient at Penn State Health, Hershey Medical Center.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 24 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 24 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Average hospital length of stay (LOS)
Secondary outcome measures
Average reduction of glycohemoglobin level within 12 months of discharge
Cost of hospitalization
Frequency of Intensive Care unit (ICU) transfers
+17 moreOther outcome measures
Provider's decision making
Provider's knowledge
Provider's perspective
+1 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Active Inpatient Diabetes Clinical Decision SupportExperimental Treatment1 Intervention
The Active arm consists of participants treated during the "ON" phase of the GlucAlert-CDS tool. The tool operates through an automated process of rules embedded in the EMR recognizing hypoglycemia (established or impending); recurrent hyperglycemia (in type 1 and 2 DM, or stress hyperglycemia-SH); and inappropriate insulin use (sliding scales monotherapy if recurrent hyperglycemia in type 2 DM or SH, or any time in type 1 DM). If the tool's criteria are met, an alert in the EMR will notify the provider with the clinically recommended treatment.
Group II: Inactive Inpatient Diabetes Clinical Decision SupportActive Control1 Intervention
The Inactive arm consists of participants treated during the "OFF" phase of the GlucAlert-CDS Tool. Alerts will not be sent to provider's
Find a Location
Who is running the clinical trial?
Milton S. Hershey Medical CenterLead Sponsor
491 Previous Clinical Trials
2,783,073 Total Patients Enrolled
2 Trials studying Diabetes
2,622,165 Patients Enrolled for Diabetes
National Institutes of Health (NIH)NIH
2,685 Previous Clinical Trials
6,915,064 Total Patients Enrolled
24 Trials studying Diabetes
48,445 Patients Enrolled for Diabetes
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,348 Previous Clinical Trials
4,299,000 Total Patients Enrolled
106 Trials studying Diabetes
122,931 Patients Enrolled for Diabetes
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am an adult patient hospitalized at a specified Penn State Health center.I am over 18 and can walk on my own. I am a patient at Penn State Health, Hershey Medical Center.You have received a warning or a message about managing a health condition.I am under 18 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Active Inpatient Diabetes Clinical Decision Support
- Group 2: Inactive Inpatient Diabetes Clinical Decision Support
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor presently seeking participants?
"As per the clinicaltrials.gov data, recruitment for this medical trial is ongoing; it was initially published on July 15th 2022 and edited most recently in August 31st of that same year."
Answered by AI
What is the capacity of this clinical trial in terms of participants?
"Affirmative. The info available on clinicaltrials.gov states that this research is in need of participants, with the trial having been initially posted on July 15th 2022 and last updated on August 31st 2022. To successfully carry out the study, 15732 people must register at two separate sites."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger